Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins.

Hematol Oncol Clin North Am

Division of Nephrology and Hypertension, Division of Hematology, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address:

Published: December 2020

AI Article Synopsis

  • - Kidney involvement is common in immunoglobulin-related amyloidosis (AIg), showing significant effects on quality of life, though it's generally less fatal than cardiac amyloidosis.
  • - The causes and mechanisms of kidney issues in AIg are still not fully understood, but there are models to help predict outcomes and responses to treatment.
  • - Patients with severe kidney damage face a poor prognosis, highlighting the need for improved therapies, while those with end-stage renal disease may benefit from kidney transplantation.

Article Abstract

Kidney involvement in immunoglobulin-related amyloidosis (AIg) is common. Although patients with renal-limited AIg tend not to have the high mortality that patients with cardiac amyloidosis have, they do experience significant morbidity and impact on quality of life. The complexity of the pathogenesis remains incompletely understood. Models have been established to prognosticate and assess for the response to therapy. Patients with advanced renal impairment from immunoglobulin light chain amyloidosis still have poor renal prognosis, and better therapy is needed in order to preserve kidney function. Patients who develop end-stage renal disease can undergo renal replacement therapy with kidney transplantation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2020.08.002DOI Listing

Publication Analysis

Top Keywords

renal
5
renal involvement
4
involvement systemic
4
amyloidosis
4
systemic amyloidosis
4
amyloidosis caused
4
caused monoclonal
4
monoclonal immunoglobulins
4
immunoglobulins kidney
4
kidney involvement
4

Similar Publications

Background: Maintenance hemodialysis (MHD) is an effective treatment for patients with end-stage renal disease. Although MHD can prolong the survival of patients, their quality of life is lower and the fatality rate is higher. This work analyzed the factors related to the autogenous arteriovenous fistula (AVF)-like expansion of non-diabetic MHD patients by vascular ultrasound (VUS).

View Article and Find Full Text PDF

Sunitinib is a first-line targeted therapy for patients with renal cell carcinoma (RCC), but resistance represents a significant obstacle to the treatment of advanced and metastatic RCC. Metabolic reprogramming is a characteristic of RCC, and changes in metabolic processes might contribute to resistance to sunitinib. Here, we identified MTHFD2, a mitochondrial enzyme involved in one-carbon metabolism, as a critical mediator of sunitinib resistance in RCC.

View Article and Find Full Text PDF

We have carried out spectral analysis of coronavirus disease 2019 (COVID-19) notifications in all 47 prefectures in Japan. The results confirm that the power spectral densities (PSDs) of the data from each prefecture show exponential characteristics, which are universally observed in the PSDs of time series generated by nonlinear dynamical systems, such as the susceptible/exposed/infectious/recovered (SEIR) epidemic model. The exponential gradient increases with the population size.

View Article and Find Full Text PDF

Importance: Cardiovascular health outcomes associated with noncigarette tobacco products (cigar, pipe, and smokeless tobacco) remain unclear, yet such data are required for evidence-based regulation.

Objective: To investigate the association of noncigarette tobacco products with cardiovascular health outcomes.

Design, Setting, And Participants: This cohort study was conducted within the Cross Cohort Collaboration Tobacco Working Group by harmonizing tobacco-related data and conducting a pooled analysis from 15 US-based prospective cohorts with data on the use of at least 1 noncigarette tobacco product ranging between 1948 and 2015.

View Article and Find Full Text PDF

The effect of the aqueous extract of (AAI) on gentamicin (GEN)-induced kidney injury was investigated. The study involves 20 adult male Wistar rats (housed in four separate plastic cages) such that graded dosages of AAI were administered to the experimental group for 14 days per oral (PO) before exposure to GEN toxicity (100 mg/kg) for 1 week. At the end of the study, comparisons of some markers of renal functions, antioxidant status, and inflammatory and apoptotic markers were made between the control, GEN, and AAI-pretreated groups at < .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!